Cargando…

Comparative analysis of multilineage properties of mesenchymal stromal cells derived from fetal sources shows an advantage of mesenchymal stromal cells isolated from cord blood in chondrogenic differentiation potential

BACKGROUND AIMS: Cord blood (CB) and amniotic fluid (AF) could represent new and attractive mesenchymal stromal cell (MSC) sources, but their potential therapeutic applications are still limited by lack of standardized protocols for isolation and differentiation. In particular, chondrogenic differen...

Descripción completa

Detalles Bibliográficos
Autores principales: Pievani, Alice, Scagliotti, Valeria, Russo, Francesca Maria, Azario, Isabella, Rambaldi, Benedetta, Sacchetti, Benedetto, Marzorati, Simona, Erba, Eugenio, Giudici, Giovanni, Riminucci, Mara, Biondi, Andrea, Vergani, Patrizia, Serafini, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062948/
https://www.ncbi.nlm.nih.gov/pubmed/24794181
http://dx.doi.org/10.1016/j.jcyt.2014.02.008
_version_ 1782321717271592960
author Pievani, Alice
Scagliotti, Valeria
Russo, Francesca Maria
Azario, Isabella
Rambaldi, Benedetta
Sacchetti, Benedetto
Marzorati, Simona
Erba, Eugenio
Giudici, Giovanni
Riminucci, Mara
Biondi, Andrea
Vergani, Patrizia
Serafini, Marta
author_facet Pievani, Alice
Scagliotti, Valeria
Russo, Francesca Maria
Azario, Isabella
Rambaldi, Benedetta
Sacchetti, Benedetto
Marzorati, Simona
Erba, Eugenio
Giudici, Giovanni
Riminucci, Mara
Biondi, Andrea
Vergani, Patrizia
Serafini, Marta
author_sort Pievani, Alice
collection PubMed
description BACKGROUND AIMS: Cord blood (CB) and amniotic fluid (AF) could represent new and attractive mesenchymal stromal cell (MSC) sources, but their potential therapeutic applications are still limited by lack of standardized protocols for isolation and differentiation. In particular, chondrogenic differentiation has never been deeply investigated. METHODS: MSCs were obtained from CB and AF samples collected during cesarean sections at term and compared for their biological and differentiation properties, with particular interest in cartilage differentiation, in which quantitative real-time polymerase chain reaction and immunohistochemical analyses were performed to evaluate the expression of type 2 collagen, type 10 collagen, SRY-box9 and aggrecan. RESULTS: We were able to isolate MSCs from 12 of 30 (40%) and 5 of 20 (25%) CB and AF units, respectively. Fluorescence in situ hybridization analysis indicated the fetal origin of isolated MSC strains. Both populations expressed mesenchymal but not endothelial and hematopoietic markers, even though we observed a lower expression of human leukocyte antigen (HLA) I in CB-MSCs. No differences in proliferation rate and cell cycle analysis could be detected. After osteogenic induction, both populations showed matrix mineralization and typical marker expression. Under chondrogenic conditions, pellets derived from CB-MSCs, in contrast with AF-MSCs pellets, were significantly larger, showed cartilage-like morphology and resulted positive for chondrocyte-associated markers, such as type 2 collagen, type 10 collagen, SRY-box9 and aggrecan. CONCLUSIONS: Our results show that CB-MSCs and AF-MSCs collected at term differ from each other in their biological and differentiation properties. In particular, only CB-MSCs showed a clear chondrogenic potential and thus could represent an ideal candidate for cartilage-tissue engineering.
format Online
Article
Text
id pubmed-4062948
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-40629482014-07-01 Comparative analysis of multilineage properties of mesenchymal stromal cells derived from fetal sources shows an advantage of mesenchymal stromal cells isolated from cord blood in chondrogenic differentiation potential Pievani, Alice Scagliotti, Valeria Russo, Francesca Maria Azario, Isabella Rambaldi, Benedetta Sacchetti, Benedetto Marzorati, Simona Erba, Eugenio Giudici, Giovanni Riminucci, Mara Biondi, Andrea Vergani, Patrizia Serafini, Marta Cytotherapy Original Paper BACKGROUND AIMS: Cord blood (CB) and amniotic fluid (AF) could represent new and attractive mesenchymal stromal cell (MSC) sources, but their potential therapeutic applications are still limited by lack of standardized protocols for isolation and differentiation. In particular, chondrogenic differentiation has never been deeply investigated. METHODS: MSCs were obtained from CB and AF samples collected during cesarean sections at term and compared for their biological and differentiation properties, with particular interest in cartilage differentiation, in which quantitative real-time polymerase chain reaction and immunohistochemical analyses were performed to evaluate the expression of type 2 collagen, type 10 collagen, SRY-box9 and aggrecan. RESULTS: We were able to isolate MSCs from 12 of 30 (40%) and 5 of 20 (25%) CB and AF units, respectively. Fluorescence in situ hybridization analysis indicated the fetal origin of isolated MSC strains. Both populations expressed mesenchymal but not endothelial and hematopoietic markers, even though we observed a lower expression of human leukocyte antigen (HLA) I in CB-MSCs. No differences in proliferation rate and cell cycle analysis could be detected. After osteogenic induction, both populations showed matrix mineralization and typical marker expression. Under chondrogenic conditions, pellets derived from CB-MSCs, in contrast with AF-MSCs pellets, were significantly larger, showed cartilage-like morphology and resulted positive for chondrocyte-associated markers, such as type 2 collagen, type 10 collagen, SRY-box9 and aggrecan. CONCLUSIONS: Our results show that CB-MSCs and AF-MSCs collected at term differ from each other in their biological and differentiation properties. In particular, only CB-MSCs showed a clear chondrogenic potential and thus could represent an ideal candidate for cartilage-tissue engineering. Elsevier 2014-07 /pmc/articles/PMC4062948/ /pubmed/24794181 http://dx.doi.org/10.1016/j.jcyt.2014.02.008 Text en © 2014 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator.
spellingShingle Original Paper
Pievani, Alice
Scagliotti, Valeria
Russo, Francesca Maria
Azario, Isabella
Rambaldi, Benedetta
Sacchetti, Benedetto
Marzorati, Simona
Erba, Eugenio
Giudici, Giovanni
Riminucci, Mara
Biondi, Andrea
Vergani, Patrizia
Serafini, Marta
Comparative analysis of multilineage properties of mesenchymal stromal cells derived from fetal sources shows an advantage of mesenchymal stromal cells isolated from cord blood in chondrogenic differentiation potential
title Comparative analysis of multilineage properties of mesenchymal stromal cells derived from fetal sources shows an advantage of mesenchymal stromal cells isolated from cord blood in chondrogenic differentiation potential
title_full Comparative analysis of multilineage properties of mesenchymal stromal cells derived from fetal sources shows an advantage of mesenchymal stromal cells isolated from cord blood in chondrogenic differentiation potential
title_fullStr Comparative analysis of multilineage properties of mesenchymal stromal cells derived from fetal sources shows an advantage of mesenchymal stromal cells isolated from cord blood in chondrogenic differentiation potential
title_full_unstemmed Comparative analysis of multilineage properties of mesenchymal stromal cells derived from fetal sources shows an advantage of mesenchymal stromal cells isolated from cord blood in chondrogenic differentiation potential
title_short Comparative analysis of multilineage properties of mesenchymal stromal cells derived from fetal sources shows an advantage of mesenchymal stromal cells isolated from cord blood in chondrogenic differentiation potential
title_sort comparative analysis of multilineage properties of mesenchymal stromal cells derived from fetal sources shows an advantage of mesenchymal stromal cells isolated from cord blood in chondrogenic differentiation potential
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062948/
https://www.ncbi.nlm.nih.gov/pubmed/24794181
http://dx.doi.org/10.1016/j.jcyt.2014.02.008
work_keys_str_mv AT pievanialice comparativeanalysisofmultilineagepropertiesofmesenchymalstromalcellsderivedfromfetalsourcesshowsanadvantageofmesenchymalstromalcellsisolatedfromcordbloodinchondrogenicdifferentiationpotential
AT scagliottivaleria comparativeanalysisofmultilineagepropertiesofmesenchymalstromalcellsderivedfromfetalsourcesshowsanadvantageofmesenchymalstromalcellsisolatedfromcordbloodinchondrogenicdifferentiationpotential
AT russofrancescamaria comparativeanalysisofmultilineagepropertiesofmesenchymalstromalcellsderivedfromfetalsourcesshowsanadvantageofmesenchymalstromalcellsisolatedfromcordbloodinchondrogenicdifferentiationpotential
AT azarioisabella comparativeanalysisofmultilineagepropertiesofmesenchymalstromalcellsderivedfromfetalsourcesshowsanadvantageofmesenchymalstromalcellsisolatedfromcordbloodinchondrogenicdifferentiationpotential
AT rambaldibenedetta comparativeanalysisofmultilineagepropertiesofmesenchymalstromalcellsderivedfromfetalsourcesshowsanadvantageofmesenchymalstromalcellsisolatedfromcordbloodinchondrogenicdifferentiationpotential
AT sacchettibenedetto comparativeanalysisofmultilineagepropertiesofmesenchymalstromalcellsderivedfromfetalsourcesshowsanadvantageofmesenchymalstromalcellsisolatedfromcordbloodinchondrogenicdifferentiationpotential
AT marzoratisimona comparativeanalysisofmultilineagepropertiesofmesenchymalstromalcellsderivedfromfetalsourcesshowsanadvantageofmesenchymalstromalcellsisolatedfromcordbloodinchondrogenicdifferentiationpotential
AT erbaeugenio comparativeanalysisofmultilineagepropertiesofmesenchymalstromalcellsderivedfromfetalsourcesshowsanadvantageofmesenchymalstromalcellsisolatedfromcordbloodinchondrogenicdifferentiationpotential
AT giudicigiovanni comparativeanalysisofmultilineagepropertiesofmesenchymalstromalcellsderivedfromfetalsourcesshowsanadvantageofmesenchymalstromalcellsisolatedfromcordbloodinchondrogenicdifferentiationpotential
AT riminuccimara comparativeanalysisofmultilineagepropertiesofmesenchymalstromalcellsderivedfromfetalsourcesshowsanadvantageofmesenchymalstromalcellsisolatedfromcordbloodinchondrogenicdifferentiationpotential
AT biondiandrea comparativeanalysisofmultilineagepropertiesofmesenchymalstromalcellsderivedfromfetalsourcesshowsanadvantageofmesenchymalstromalcellsisolatedfromcordbloodinchondrogenicdifferentiationpotential
AT verganipatrizia comparativeanalysisofmultilineagepropertiesofmesenchymalstromalcellsderivedfromfetalsourcesshowsanadvantageofmesenchymalstromalcellsisolatedfromcordbloodinchondrogenicdifferentiationpotential
AT serafinimarta comparativeanalysisofmultilineagepropertiesofmesenchymalstromalcellsderivedfromfetalsourcesshowsanadvantageofmesenchymalstromalcellsisolatedfromcordbloodinchondrogenicdifferentiationpotential